NCT02993575View on ClinicalTrials.gov

Pharmacokinetics of Flucloxacillin Given by Continuous or Intermittent Infusion to ICU Patients

CompletedOBSERVATIONAL
Enrollment

30

Participants

Timeline

Start Date

June 1, 2017

Primary Completion Date

March 1, 2018

Study Completion Date

April 1, 2018

Conditions
Bacterial Infections
Interventions
DRUG

Flucloxacillin

Dose according to summary of product characteristics (SPC) or local protocols: intermittent and continuous infusion

Trial Locations (1)

Unknown

Radboud University Medical Center, Nijmegen

All Listed Sponsors
collaborator

Canisius-Wilhelmina Hospital

OTHER

collaborator

Rijnstate Hospital

OTHER

collaborator

UMC Utrecht

OTHER

collaborator

Tergooi Hospital

OTHER

collaborator

Gelderse Vallei Hospital

OTHER

lead

Radboud University Medical Center

OTHER

NCT02993575 - Pharmacokinetics of Flucloxacillin Given by Continuous or Intermittent Infusion to ICU Patients | Biotech Hunter | Biotech Hunter